SUMMARY Twenty-eight patients with resistant hypertension were found to have primary aldosteronism; 25 had solitary adenoma and 3 had adrenal hyperplasia. All were severely hypertensive despite receiving three or more antihypertensive agents, including conventional doses of diuretics, sympatholytics, and vasodilators. Hypervolemia (24 patients) or normovolemia (2 patients) despite severe diastolic hypertension was the hallmark in 26 patients. Adequate salt and water depletion alone with spironolactone (200 mg/day) and hydrochlorothiazide (50-100 ng/day) reduced arterial pressure in all. Twenty-two patients had surgical removal of a solitary adenoma. Over 1 to 2 years of follow-up, 13 were normotensive without medication, and six required hydrochlorothiazide and three hydrochlorothiazide plus a /3-blocker to normalize blood pressure. Blood pressure response to surgery had no relation to either duration or severity of hypertension. Six patients (three with hyperplasia, three with adenoma) have continued diuretic therapy and are normokalemic and normotensive. These results indicate that primary aldosteronism can be associated with severe and drug-resistant hypertension, that maintained hypervolemia is the reason for resistance to therapy, that sustained volume depletion is the most important therapeutic goal for these patients, and that cure can be achieved despite prolonged and severe hypertension. 
An initial survey by their referring physicians revealed the absence of renal arterial disease, renal parenchymal disease, Cushing's syndrome, or pheochromocytoma. They were evaluated for primary aldosteronism because of significant hypokalemia with conventional diuretic therapy. 1 
Patient Evaluation
Data were collected on unrestricted dietary sodium at the following phases of the patients' clinical course: 1) at initial evaluation when the patients were still taking their prescribed medications; 2) 8 to 12 weeks after they had been taking diuretic therapy alone; and 3) from 1 to 2 years after surgical removal of a solitary adenoma in 22 patients.
At initial evaluation, patients had a complete physical examination, urinalysis, complete blood cell count and differential, chest roentgenogram, electrocardiogram (ECG), and measurement of serum electrolytes, blood urea nitrogen (BUN), serum creatinine, blood volume, plasma renin activity (PRA), plasma aldosterone concentration (PAQ, and plasma norepinephrine. Medications were then discontinued stepwise either in the hospital or in the outpatient department. After at least 14 days without medications, patients were hospitalized and underwent metabolic studies to assess the integrity of the renin-angiotensin-aldosterone sys-tem. An adrenal computed tomographic (CT) scan was performed after the metabolic studies. If the CT scan did not reveal a definitive mass, both adrenal veins were sampled to determine aldosterone and cortisol concentrations. The definitive diagnosis of hyperplasia or adenoma was based on previously published criteria. 1 After diagnostic and localization procedures, patients started taking spironolactone, 200 mg/day, to which hydrochlorothiazide, 50 to 100 mg/day, was added a week later. Patients continued this combination and were followed in the outpatient department until surgery. The following were measured at 2-to 4-week intervals: sitting and standing blood pressures, serum electrolytes, BUN, serum creatinine, blood volume, PRA, and PAC.
Surgery was advised for those with solitary adenoma confined to one adrenal gland. It was performed after the patient had been normokalemic and normotensive with medical therapy for at least 3 months. The patients were asked to return for a visit 4 weeks after surgery, at 3-month intervals thereafter for the first year, and then at 6-month intervals for the second year. The following were measured at each visit: sitting and standing arterial pressures, serum electrolytes, BUN, serum creatinine, blood volume, PRA, and PAC.
All blood pressure readings used in this analysis were taken in the outpatient department with a standard sphygmomanometer with the patient seated. Values are averages of at least three readings taken 1 minute apart.
Analytical Methods
Blood samples for the estimation of plasma volume and the basal values of serum electrolytes, PRA, PAC, and plasma norepinephrine were drawn together in the morning (between 0800 and 0900) under fasting conditions after at least 30 to 45 minutes of supine rest. Blood was collected by gentle aspiration without the aid of a tourniquet through a plastic tubing with a 21-gauge needle inserted into an antecubital vein. Plasma volume was measured with 123 I-human serum albumin with a 10-minute equilibration period as 
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previously described. 5 The coefficient of variation for this method is ± 8%. Values are expressed as milliliters per centimeter of height to minimize individual differences in body fat, and as percentage of normal to include values for both men and women. PRA was estimated by radioimmunoassay of generated angiotensin I during incubation of 1.0 ml plasma for 3 hours at pH 5.7. 6 Normal supine resting values average 1.18 ±0.37 (SD) ng/ml/hr. Plasma aldosterone concentration was measured by a previously described radioimmunoassay technique. 7 Normal supine resting values average 12.7 ± 4.9 ng/dl. Plasma norepinephrine was measured by a previously described radioenzymatic assay*; normal resting values average 218 ± 92 pg/ml.
Statistical Analysis
Statistical analyses were performed by accepted methods for calculation of group differences and their statistical significance. Student's t test was used for paired data analysis.' All values were expressed as means ± SEM.
Results

Clinical and Biochemical Profile
The patients, 17 men and 11 women, ranged in age from 20 to 65 years (median, 43.7 years; Table 1 ). Duration of hypertension ranged from 1 to 21 years (median, 7.8 years). Resting arterial pressures ranged from 148 to 209 mm Hg systolic, 100 to 144 mm Hg diastolic (median, 186/118 mm Hg). Funduscopic examination revealed grade I hypertensive retinopathy in two patients, grade II in 24, and grade in in two. The ECG was normal in 11; myocardial changes were evident in 12, changes suggestive of left ventricular hypertrophy in two, and old inferior myocardial infarction in three.
Eight patients were receiving at most three drugs; 10 were taking four drugs, 9, five drugs, and 1, seven drugs. The following medications in various combinations were prescribed: calcium channel blocker (1 patient), a-adrenergic blocker (5 patients), potassiumsparing agent (7 patients), converting enzyme inhibitor (8 patients), oral KC1 supplement (12 patients), vasodilator (15 patients), /3-adrenergic blocker (19 patients), centrally acting agent (20 patients), and diuretic (26 patients). Diuretics were mostly in the form of hydrochlorothiazide (25-50 mg/day) with or without spironolactone (25-50 mg/day).
The following biochemical profile was obtained at initial evaluation: serum sodium averaged 143 ± 1, serum potassium 2.8 ± 0 . 1 , chloride 101 ± 1, and bicarbonate 32 ± 1 mEq/L. The BUN averaged 13 ± 1 and serum creatinine 1.1 ± 0 . 1 mg/dl. Plasma volume averaged 114 ± 3% of normal, PRA 0.5 ± 0.2 ng/ml/hr, and PAC 48.8 ± 4.7 ng/dl. Plasma norepinephrine ranged from 111 to 425 pg/ml; these values were within the upper 95% confidence limits (i.e., 811 pg/ml) for essential hypertension.
After metabolic balance studies and localization procedures, three patients (Nos. 8, 11, and 22) were considered to have hyperplasia. Twenty-five patients had biochemical evidence of adenoma; of these, 23 had solitary adenomas demonstrated by adrenal CT scan, while in two patients adrenal venous sampling for PAC and plasma cortisol localized the site of the tumor to one gland.
Long-term Studies: Effectiveness of Diuretic Therapy Alone Table 2 shows the effect of combining spironolactone (200 mg/day) and hydrochlorothiazide (50-100 mg/day) on MAP, plasma volume, serum potassium, PRA, and PAC. Values were obtained after 8 to 12 weeks of continued therapy. MAP was reduced significantly in all; as a group it fell from 138 ± 2 to 103 ± A = multiple drug therapy; B = salt and water depletion (8) (9) (10) (11) (12) weeks) with spironolactone (200 mg/day) and hydrochlorothiazide (50-100 mg/day). NM = not measured.
•Adrenal hyperplasia. 
Arterial Pressure Response to Surgery
Of the 25 patients with solitary adenoma, 22 underwent surgery (Table 3) . In all, a solitary tumor was identified and excised. At 1 to 2 years of follow-up, 13 had normal or near-normal arterial pressure without medication, and nine had residual hypertension. For the latter group, the number and dosages of drugs required to normalize arterial pressure were far less than those prescribed at the initial assessment. Neither duration nor severity of hypertension had any relationship to the arterial blood pressure achieved after surgical removal of the tumor.
Discussion
The hypertension associated with primary aldosteronism is often described as mild to moderate and easy to manage. Severe hypertension is considered rare, as is drug resistance. The present report indicates that the hypertension of primary aldosteronism is often severe and is consistent with observations of other investigators.
As currently defined, 10 there is no question that the hypertension of these patients was drug-resistant. All were markedly hypertensive despite receiving various drug combinations reserved only for the severely hypertensive patient. The possibility of Cushing's syndrome, pheochromocytoma, or renovascular hypertension had been ruled out in previous assessments. In addition, none had the clinical characteristics of Cushing's syndrome. Plasma catecholamine values were not elevated, PRA values were suppressed in all but one patient, and all had normal renal function. Furthermore, there was no indication of noncompliance, and when this was in question patients were usually hospitalized to control drug therapy.
The most likely explanation for drug resistance in these patients is the lack of sustained salt and water depletion. All but two patients had either normal or significant increases in plasma volume despite marked elevations of diastolic arterial pressure. The marked pressure responsiveness of these patients to reducing plasma volume suggests that arterial pressure control depended upon the response of intravascular volume. 
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The marked depressor responsiveness of these patients to sustained salt and water depletion does not necessarily imply that intravascular volume is the determining factor in this form of hypertension. However, the potent effects of aldosterone on salt and water retention reasonably suggest that hypervolemia might have had a role in initiating the pressure rise and might then have been superseded or even partially reversed by other mechanisms. One could speculate that a secondary rise of resistance after an initial increase in volume would establish new levels of equilibrium. Alternatively, changes in plasma volume might only be a sign of more basic disturbances in sodium distribution.
Drugs that suppress sympathetic vasomotor activity have the potential of increasing plasma volume, thus diminishing their therapeutic effectiveness. 12 In the short term, this occurs without change in body weight and probably results from transfer of fluid from the interstitial to intravascular compartment. Over the long term, extracellular fluid volume expands with weight gain, indicating fluid retention. This study emphasizes how potent this influence can become, since amounts of diuretics that are usually adequate to prevent fluid retention failed to do so. In addition, it reiterates an important therapeutic principle that salt-and waterdependent hypertension responds poorly to antihypertensive agents that cause fluid retention or fail to reduce the existing hypervolemia. 13 - 14 These include all drugs that suppress sympathetic vasomotor activity, calcium entry blocking agents, converting enzyme inhibitors, and direct arterial vasodilators.
The predictive value of spironolactone in indicating the likely hypotensive effect of adrenal surgery was emphasized by Brown et al. 2 In that study, however, the drug was equally effective in controlling arterial pressure in patients with and without adenomas, although in the latter, arterial pressure rarely responds favorably to adrenal surgery. In a similar study" we showed that any measure reducing plasma volume in patients with primary aldosteronism (whether by sodium deprivation or combining hydrochlorothiazide with small doses of spironolactone) resulted in normalization of arterial pressure. This indicates that the ability of spironolactone to reduce arterial pressure in primary aldosteronism is largely dependent on salt and water balance and not on any specific antagonism of the effects of aldosterone on vascular resistance.
Neither duration nor severity of hypertension influenced arterial pressure response to surgery. In an earlier study of 16 patients, Tarazi et al. l5 reported that the best surgical results were obtained in those with higher cardiac output before operation. Patients did not differ in the duration of known hypertension. The authors emphasized that higher output implies lower peripheral resistance and hence presumably lesser vascular disease. In the present study, there was no indication that patients with residual hypertension had more vascular disease than those who became normotensive after surgery; the degree of end-organ target involvement (kidney, heart, and fundi) was not different between responders and nonresponders. This apart, surgery rendered arterial pressure easier to control with medications in those with residual hypertension.
